The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| NATERA INC | COM | 632307104 | 353,525 | 2,500 | SH | SOLE | 2,500 | 0 | 0 | ||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 1,836,225 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| KESTRA MED TECHNOLOGIES LTD | SHS | G52441105 | 996,800 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| INSPIREMD INC | COM | 45779A846 | 1,211,891 | 450,517 | SH | SOLE | 450,517 | 0 | 0 | ||
| ONCOCYTE CORP | COM NEW | 68235C206 | 2,898,230 | 947,134 | SH | SOLE | 947,134 | 0 | 0 | ||
| BETA BIONICS INC | COM | 08659B102 | 5,252,429 | 429,120 | SH | SOLE | 429,120 | 0 | 0 | ||
| OUTSET MED INC | COM NEW | 690145206 | 783,417 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
| METAGENOMI INC | COM | 59102M104 | 359,572 | 264,391 | SH | SOLE | 264,391 | 0 | 0 | ||